C
CytomX Therapeutics
Biotech & Life Sciences · South San Francisco, United States · Founded 2008 · IPO 2015
CytomX Therapeutics mafia
Startups founded by CytomX Therapeutics alumni
Former CytomX Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.
Global footprint
Where CytomX Therapeutics has talent and traffic
team presence
across markets
Talent graph
The shape of CytomX Therapeutics's talent
Dealroom maps CytomX Therapeutics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$156M patent portfolio · 80 active families
Where CytomX Therapeutics concentrates vs peers
Each axis is a top-10 topic across CytomX Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about CytomX Therapeutics
An AI-synthesized read of the highest-engagement posts about CytomX Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CytomX Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.